Longitudinal Performance of Epi proColon
NCT03218423 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4500
Last updated 2021-11-01
Summary
This study will evaluate longitudinal performance of Epi proColon with respect to test positivity, longitudinal adherence to Epi proColon screening, adherence to follow-up colonoscopy and diagnostic yield, as well as assay failure rates.
Conditions
- Colorectal Cancer
- Colorectal Neoplasms
Interventions
- DEVICE
-
Epi proColon
Plasma cell free DNA SEPT9 promoter methylation test for colorectal cancer screening.
Sponsors & Collaborators
-
Epigenomics, Inc
lead INDUSTRY
Principal Investigators
-
Theo deVos, PhD · Epigenomics, Inc
Eligibility
- Min Age
- 50 Years
- Max Age
- 74 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-08-18
- Primary Completion
- 2023-08-31
- Completion
- 2024-01-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval
NCT02419716 ·Status: COMPLETED
-
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
NCT00843375 ·Status: RECRUITING
-
Reducing Rural Colon Cancer Disparities
NCT03457454 ·Status: COMPLETED
-
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
NCT01260168 ·Status: COMPLETED
-
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NCT05612347 ·Status: RECRUITING ·Phase: NA
-
Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer
NCT05115786 ·Status: UNKNOWN
-
Comparative Effectiveness of FITs With Colonoscopy
NCT03264898 ·Status: COMPLETED
-
Early Detection of Advanced Adenomas and Colorectal Cancer
NCT06342440 ·Status: RECRUITING
-
PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening
NCT00855348 ·Status: COMPLETED
-
Screening and Risk Factors of Colon Neoplasia
NCT01647776 ·Status: COMPLETED
-
Clinical Application of an Automated Liquid Biopsy Platform for Early Detection of Colorectal Cancer
NCT03476122 ·Status: UNKNOWN
-
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
NCT03821948 ·Status: COMPLETED
-
Screening With a DNA Blood Test to Address Colorectal Cancer Inequities
NCT06929481 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
NCT02503631 ·Status: TERMINATED
-
Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal Cancer
NCT02324114 ·Status: UNKNOWN ·Phase: NA
-
Stool Sample Collection Study
NCT06294873 ·Status: RECRUITING
-
Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older Adults
NCT05021172 ·Status: COMPLETED ·Phase: NA
-
Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up
NCT04514341 ·Status: COMPLETED
-
Study of Gut Microbiome and Colorectal Tumors
NCT03297996 ·Status: COMPLETED
-
Assessing Repeat Fit Testing for CRC
NCT03248661 ·Status: COMPLETED ·Phase: PHASE3
-
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
NCT03789162 ·Status: COMPLETED
-
CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population
NCT02540850 ·Status: COMPLETED
-
Educational Intervention - Improving Knowledge and Screening Rates for Colorectal Cancer
NCT03287453 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Point-of-care Testing Instrument for Fecal Immunochemical Test
NCT05232721 ·Status: UNKNOWN
-
Assessing the Effect of a Blood-based Colorectal Cancer Screening Test on Screening Adherence and Colonoscopy Completion
NCT03598166 ·Status: COMPLETED ·Phase: NA